Howe & Rusling’s Bausch Health BHC Stock Holding History

Howe & Rusling’s Portfolio BHC Stock Details BHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-2,000	Closed	-$63K	–	945
2021 Q1	$63K	Sell	2,000 -2,000	-50%	-$58.7K	0.01%	274
2020 Q4	$83K	Buy	+4,000	New	+$74.6K	0.01%	241

Other funds holding BHC

Icahn Carl Sunny Isles Beach, Florida $8.55B AUM 29.29% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

GAM

Goldentree Asset Management New York $1.69B AUM 10.69% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Natixis Paris, France $28B AUM 26.79% 1-Year Est. Return

National Bank of Canada Montreal, Quebec, Canada $112B AUM 31.26% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return

Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

LCM

Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

Howe & Rusling's BHC Position: Q4 2022 in Review

Howe & Rusling sold out of Bausch Health (BHC) in Q4 2022, closing a stake of 100 shares — an estimated $1K sold.

Howe & Rusling first reported a position in BHC in Q1 2015 and held it in 22 quarters. The position peaked at $128K in Q1 2021. 262 funds tracked by Wall St. Rank hold BHC as of Q4 2022.

Howe & Rusling reported no remaining Bausch Health position as of Q4 2022 after selling out during the quarter.
Howe & Rusling sold 100 Bausch Health shares in Q4 2022, an estimated $1K.
Howe & Rusling first reported a position in Bausch Health in Q1 2015 and held it in 22 quarters.
Howe & Rusling's Bausch Health position peaked at $128K in Q1 2021.
262 funds tracked by Wall St. Rank held Bausch Health as of Q4 2022.

Based on Howe & Rusling's 13F filing for Q4 2022, filed 15 Feb 2023.